Oxycodone is commonly prescribed for moderate to severe pain disorders. While efficacious, long-term use can result in tolerance, physical dependence, and the development of opioid use disorder. Cannabis and its derivatives such as Δ9-Tetrahydrocannabinol (Δ9-THC) have been reported to enhance oxycodone analgesia in animal models and in humans. However, it remains unclear if Δ9-THC may facilitate unwanted aspects of oxycodone intake, such as tolerance, dependence, and reward at analgesic doses. This study sought to evaluate the impact of co-administration of Δ9-THC and oxycodone across behavioral measures related to antinociception, dependence, circadian activity, and reward in both male and female mice. Oxycodone and Δ9-THC produced dose-dependent antinociceptive effects in the hotplate assay that were similar between sexes. Repeated treatment (twice daily for 5 days) resulted in antinociceptive tolerance. Combination treatment of oxycodone and Δ9-THC produced a greater antinociceptive effect than either administered alone, and delayed the development of antinociceptive tolerance. Repeated treatment with oxycodone produced physical dependence and alterations in circadian activity, neither of which were exacerbated by co-treatment with Δ9-THC. Combination treatment of oxycodone and Δ9-THC produced CPP when co-administered at doses that did not produce preference when administered alone. These data indicate that Δ9-THC may facilitate oxycodone-induced antinociception without augmenting certain unwanted features of opioid intake (e.g. dependence, circadian rhythm alterations). However, our findings also indicate that Δ9-THC may facilitate rewarding properties of oxycodone at therapeutically relevant doses which warrant consideration when evaluating this combination for its potential therapeutic utility.

Diets that are high in fat cause overeating and weight gain in multiple species of animals, suggesting that high dietary fat is sufficient to cause obesity. However, high-fat diets are typically provided freely to animals in obesity experiments, so it remains unclear whether high-fat diets would still cause obesity if these diets required more effort to obtain. We hypothesized that unrestricted access to high-fat diets is important for these diets to induce overeating and that requiring mice to perform small amounts of work to obtain a high-fat diet would reduce calorie intake and associated weight gain. To test this hypothesis, we developed a novel home-cage-based feeding device that provided the high-fat diet in two conditions: either freely or after mice poked their noses into a port one time-a simple action that is easy for them to do. Consistent with our hypothesis, requiring mice to nose-poke reduced high-fat diet intake and nearly completely prevented weight gain. Requiring mice to nose-poke also reduced low-fat grain-based pellet intake, confirming that this is a general mechanism governing food choice and not something specific to a high-fat diet. We conclude that unrestricted access to food promotes overeating and that requiring a simple action such as a nose-poke can reduce overeating and weight gain in mice. Our results may have implications for why overeating and obesity are common in modern food environments, which are often characterized by easy access to low-cost unhealthy foods.

Obesity is a chronic relapsing disorder that is caused by an excess of caloric intake relative to energy expenditure. In addition to homeostatic feeding mechanisms, there is growing recognition of the involvement of food reward and motivation in the development of obesity. However, it remains unclear how brain circuits that control food reward and motivation are altered in obese animals. Here, we tested the hypothesis that signaling through pro-motivational circuits in the core of the nucleus accumbens (NAc) is enhanced in the obese state, leading to invigoration of food seeking. Using a novel behavioral assay that quantifies physical work during food seeking, we confirmed that obese mice work harder than lean mice to obtain food, consistent with an increase in the relative reinforcing value of food in the obese state. To explain this behavioral finding, we recorded neural activity in the NAc core with both in vivo electrophysiology and cell-type specific calcium fiber photometry. Here we observed greater activation of D1-receptor expressing NAc spiny projection neurons (NAc D1 SPNs ) during food seeking in obese mice relative to lean mice. With ex vivo slice physiology we identified both pre- and post-synaptic mechanisms that contribute to this enhancement in NAc D1 SPN activity in obese mice. Finally, blocking synaptic transmission from D1 SPNs decreased physical work during food seeking and attenuated high-fat diet-induced weight gain. These experiments demonstrate that obesity is associated with a selective increase in the activity of D1 SPNs during food seeking, which enhances the vigor of food seeking. This work also establishes the necessity of D1 SPNs in the development of diet-induced obesity, establishing these neurons as a potential therapeutic target for preventing obesity.

Lipids contribute to the structure, development, and function of healthy brains. Dysregulated lipid metabolism is linked to aging and diseased brains. However, our understanding of lipid metabolism in aging brains remains limited. Here we examined the brain lipidome of mice across their lifespan using untargeted lipidomics. Co-expression network analysis highlighted a progressive decrease in 3-sulfogalactosyl diacylglycerols (SGDGs) and SGDG pathway members, including the potential degradation products lyso-SGDGs. SGDGs show an age-related decline specifically in the central nervous system and are associated with myelination. We also found that an SGDG dramatically suppresses LPS-induced gene expression and release of pro-inflammatory cytokines from macrophages and microglia by acting on the NF-κB pathway. The detection of SGDGs in human and macaque brains establishes their evolutionary conservation. This work enhances interest in SGDGs regarding their roles in aging and inflammatory diseases and highlights the complexity of the brain lipidome and potential biological functions in aging.

Feeding is critical for survival, and disruption in the mechanisms that govern food intake underlies disorders such as obesity and anorexia nervosa. It is important to understand both food intake and food motivation to reveal mechanisms underlying feeding disorders. Operant behavioral testing can be used to measure the motivational component to feeding, but most food intake monitoring systems do not measure operant behavior. Here, we present a new solution for monitoring both food intake and motivation in rodent home-cages: the Feeding Experimentation Device version 3 (FED3). FED3 measures food intake and operant behavior in rodent home-cages, enabling longitudinal studies of feeding behavior with minimal experimenter intervention. It has a programmable output for synchronizing behavior with optogenetic stimulation or neural recordings. Finally, FED3 design files are open-source and freely available, allowing researchers to modify FED3 to suit their needs.

Fatty acid esters of hydroxy fatty acids (FAHFAs) are a newly discovered class of signaling lipids with anti-inflammatory and anti-diabetic properties. However, the endogenous regulation of FAHFAs remains a pressing but unanswered question. Here, using MS-based FAHFA hydrolysis assays, LC-MS?based lipidomics analyses, and activity-based protein profiling, we found that androgen-induced gene 1 (AIG1) and androgen-dependent TFPI-regulating protein (ADTRP), two threonine hydrolases, control FAHFA levels in vivo in both genetic and pharmacologic mouse models. Tissues from mice lacking ADTRP (Adtrp-KO), or both AIG1 and ADTRP (DKO) had higher concentrations of FAHFAs particularly isomers with the ester bond at the 9(th) carbon due to decreased FAHFA hydrolysis activity. The levels of other lipid classes were unaltered indicating that AIG1 and ADTRP specifically hydrolyze FAHFAs. Complementing these genetic studies, we also identified a dual AIG1/ADTRP inhibitor, ABD-110207, which is active in vivo. Acute treatment of WT mice with ABD-110207 resulted in elevated FAHFA levels, further supporting the notion that AIG1 and ADTRP activity control endogenous FAHFA levels. However, loss of AIG1/ADTRP did not mimic the changes associated with pharmacologically administered FAHFAs on extent of upregulation of FAHFA levels, glucose tolerance, or insulin sensitivity in mice, indicating that therapeutic strategies should weigh more on FAHFA administration. Together, these findings identify AIG1 and ADTRP as the first endogenous FAHFA hydrolases identified and provide critical genetic and chemical tools for further characterization of these enzymes and endogenous FAHFAs to unravel their physiological functions and roles in health and disease.

Androgen‐induced gene 1 (AIG1) and Androgen‐dependent TFPI‐regulating protein (ADTRP) are atypical transmembrane hydrolases that rely on a catalytic threonine for their enzymatic activity. In vitro characterization of AIG1 and ADTRP in lysates and cells identified fatty acid ester of hydroxy fatty acids (FAHFAs) as their putative substrates. Here, we generate ADTRP knockout (Adtrp‐KO), AIG1 knockout (Aig1‐KO), and ADTRP/AIG1 double deficient (DKO) mice using CRISPR‐Cas9 technology to test whether these enzymes regulate FAHFAs in vivo. AIG1, ADTRP, or a deficiency in both enzymes leads to decreased FAHFA hydrolytic activity in tissue lysates. Quantitative measurement of FAHFA levels in several tissues revealed increased FAHFA levels in brown adipose tissue (BAT), subcutaneous adipose tissue (SQWAT), and perigonadal WAT (PGWAT) of Adtrp‐KO mice consistent with the loss of FAHFA degrading activity. Furthermore, contribution by AIG1 was modest and only observed in the kidney and BAT of DKO mice. Lipidomics of tissues from knockout and wild type control mice detected no significant changes in other lipid classes to indicate that these enzymes are specific for FAHFA substrates. Furthermore, we developed a potent and selective, dual AIG1/ADTRP inhibitor to enable pharmacological interrogation of these enzymes in vivo. Chemical inhibition of AIG1 and ADTRP raised FAHFA levels demonstrating acute regulation of FAHFAs. In aggregate, the results establish AIG1 and ADTRP as the only endogenous FAHFA hydrolases known, and describe resources (mice, inhibitors) needed to elucidate the biochemical and physiological role of these exciting enzymes.Support or Funding InformationThis research was supported by the NIH (DK106210, DK114785, DA033760), The Leona M. and Harry B. Helmsley Charitable Trust (grant #2012‐PG‐MED002 to A.S.), NCI Cancer Center Support Grant P30 (CA014195 MASS core, A.S.), Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals (A.S.), a NIH F32 postdoctoral fellowship, DK111159 (M.EE.), a Hewitt Foundation for Medical Research Fellowship (W.H.P.), Mass Spectrometry Core of the Salk Institute with funding from NIH‐NCI CCSG: P30 014195, NIH 1S10OD021815‐01 and the Helmsley Center for Genomic Medicine, and Transgenic Core Facility of the Salk Institute with funding from NIH‐NCI CCSG: P30 014195.

Although glucose-sensing neurons were identified more than 50 years ago, the physiological role of glucose sensing in metazoans remains unclear. Here we identify a pair of glucose-sensing neurons with bifurcated axons in the brain of Drosophila. One axon branch projects to insulin-producing cells to trigger the release of Drosophila insulin-like peptide 2 (dilp2) and the other extends to adipokinetic hormone (AKH)-producing cells to inhibit secretion of AKH, the fly analogue of glucagon. These axonal branches undergo synaptic remodelling in response to changes in their internal energy status. Silencing of these glucose-sensing neurons largely disabled the response of insulin-producing cells to glucose and dilp2 secretion, disinhibited AKH secretion in corpora cardiaca and caused hyperglycaemia, a hallmark feature of diabetes mellitus. We propose that these glucose-sensing neurons maintain glucose homeostasis by promoting the secretion of dilp2 and suppressing the release of AKH when haemolymph glucose levels are high.

Sweet-insensitive Drosophila mutants are unable to readily identify sugar. In presence of wild-type (WT) flies, however, these mutant flies demonstrated a marked increase in their preference for nutritive sugar. Real-time recordings of starved WT flies revealed that these flies discharge a drop from their gut end after consuming nutritive sugars, but not nonnutritive sugars. We proposed that the drop may contain a molecule(s) named calorie-induced secreted factor (CIF), which serves as a signal to inform other flies about its nutritional value. Consistent with this, we observed a robust preference of flies for nutritive sugar containing CIF over nutritive sugar without CIF. Feeding appears to be a prerequisite for the release of CIF, given that fed flies did not produce it. Additionally, correlation analyses and pharmacological approaches suggest that the nutritional value, rather than the taste, of the consumed sugar correlates strongly with the amount (or intensity) of the released CIF. We observed that the release of this attractant signal requires the consumption of macronutrients, specifically nutritive sugars and L-enantiomer essential amino acids (L-eAAs), but it is negligibly released when flies are fed nonnutritive sugars, unnatural D-enantiomer essential amino acids (D-eAAs), fatty acids, alcohol, or salts. Finally, CIF (i) is not detected by the olfactory system, (ii) is not influenced by the sex of the fly, and (iii) is not limited to one species of Drosophila.